CellR4 2022;
10: e3330
DOI: 10.32113/cellr4_202210_3330
Corrigendum – Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence
Topic: Diabetes, Immune Regulation, Islet transplantation
Category: Corrigendum
Corrigendum on: Incorrect Funding
In the published article, there was an error in the Funding statement. The authors have omitted to acknowledge “Horizon 2020 Framework Program; VANGUARD grant 874700” as a funding agency. The correct Funding statement appears below.
Funding
This study was funded by a grant from the Swiss National Science Foundation (grant # 310030–149798) and by a grant from the Horizon 2020 Framework Program (VANGUARD grant # 874700).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
To cite this article
Corrigendum – Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence
CellR4 2022;
10: e3330
DOI: 10.32113/cellr4_202210_3330
Publication History
Submission date: 27 Oct 2022
Revised on: 27 Oct 2022
Accepted on: 27 Oct 2022
Published online: 27 Oct 2022
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.